

Hera BioLabs Information
Summary
Hera BioLabs is a private company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. The position of the CEO is occupied by Michael Schlosser. Its headquarters is located at Lexington, Kentucky, USA. The number of employees ranges from 25 to 100. The annual revenue of Hera BioLabs varies between 5.0M and 25M. To connect with Hera BioLabs employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
Specialties
piggyBac® Transposon System, Cas-Clover™ Dimeric Nuclease, SRG Rat® Platform, Cell Line Development , CHO Cell Line Development, Gene Editing Reagents, Custom Preclinical Models, Potency Assays, Synthetic Biotechnology , Gene Editing Technologies, Super piggyBac® Transposase, Genetically Engineered Rat Model
DMA Code
Lexington–fayette Metropolitan Area
Founded
2014
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
1993 | Public Company | 1.0K - 5.0K | 639.4M | $220.6M | |
1999 | Privately Held | 1.0K - 5.0K | 165M | $5M | |
2003 | Privately Held | 25 - 100 | 14M | $0 | |
1995 | Privately Held | 1.0K - 5.0K | 140M | $0 | |
1993 | Public Company | 5.0K - 10K | 306.5M | $0 | |
2010 | - | 10-50 | - | $- | |
2000 | - | 100-200 | - | $- | |
1989 | - | 1000-5000 | - | $- | |
2003 | - | 100-200 | - | $- | |
- | - | 1000-5000 | - | $- |